O-GlcNAcylation and Cancer / / edited by Ikram El Yazidi-Belkoura and Tony Lefebvre.

This book gathers reviews and articles on the role of O-GlcNAcylation in cancer underlying the pharmacological targeting of the O-GlcNAcylation enzymes OGT and OGA as a promising anticancer strategy. Particular attention is paid to the involvement of O-GlcNAcylation in the regulation of transcriptio...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022.
Year of Publication:2022
Language:English
Physical Description:1 online resource (112 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993562132804498
ctrlnum (CKB)4920000001372612
(NjHacI)994920000001372612
(EXLCZ)994920000001372612
collection bib_alma
record_format marc
spelling O-GlcNAcylation and Cancer / edited by Ikram El Yazidi-Belkoura and Tony Lefebvre.
Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2022.
1 online resource (112 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
This book gathers reviews and articles on the role of O-GlcNAcylation in cancer underlying the pharmacological targeting of the O-GlcNAcylation enzymes OGT and OGA as a promising anticancer strategy. Particular attention is paid to the involvement of O-GlcNAcylation in the regulation of transcription and as a link between nutrition and epigenetic dynamics or cellular energy metabolism. The role of O-GlcNAcylation in metastasis, immune responses, and resistance to chemotherapeutic agents is also discussed.
1. Introduction -- 2. O-GlcNAcylation -- 2.2. Functions of O-GlcNAcylation -- 3. O-GlcNAcylation and Cancer -- 3.1. O-GlcNAcylation and Metastasis -- 3.2. O-GlcNAcylation and Receptor Tyrosine Kinase -- 3.3. O-GlcNAcylation and Resistance to Chemotherapy -- 3.4. O-GlcNAcylation as Prognostic Marker -- 4. O-GlcNAcylation and Immune Responses in Cancer -- 4.1. Overview of Immune System and O-GlcNAcylation -- 4.2. T Cell Activation and Differentiation Regulated by O-GlcNAcylation -- 4.3. Macrophage Differentiation and Activation by O-GlcNAcylation -- 4.4. O-GlcNAcylation and Tumor Microenvironment -- 5. Cancer Therapeutics Targeting O-GlcNAcylation -- 6. Conclusions and Future Perspectives -- Author Contributions -- Funding -- Conflicts of Interest -- Footnotes -- References.
Glycosylation.
3-0365-3082-7
Yazidi-Belkoura, Ikram El, editor.
Lefebvre, Tony, editor.
language English
format eBook
author2 Yazidi-Belkoura, Ikram El,
Lefebvre, Tony,
author_facet Yazidi-Belkoura, Ikram El,
Lefebvre, Tony,
author2_variant i e y b iey ieyb
t l tl
author2_role TeilnehmendeR
TeilnehmendeR
title O-GlcNAcylation and Cancer /
spellingShingle O-GlcNAcylation and Cancer /
1. Introduction -- 2. O-GlcNAcylation -- 2.2. Functions of O-GlcNAcylation -- 3. O-GlcNAcylation and Cancer -- 3.1. O-GlcNAcylation and Metastasis -- 3.2. O-GlcNAcylation and Receptor Tyrosine Kinase -- 3.3. O-GlcNAcylation and Resistance to Chemotherapy -- 3.4. O-GlcNAcylation as Prognostic Marker -- 4. O-GlcNAcylation and Immune Responses in Cancer -- 4.1. Overview of Immune System and O-GlcNAcylation -- 4.2. T Cell Activation and Differentiation Regulated by O-GlcNAcylation -- 4.3. Macrophage Differentiation and Activation by O-GlcNAcylation -- 4.4. O-GlcNAcylation and Tumor Microenvironment -- 5. Cancer Therapeutics Targeting O-GlcNAcylation -- 6. Conclusions and Future Perspectives -- Author Contributions -- Funding -- Conflicts of Interest -- Footnotes -- References.
title_full O-GlcNAcylation and Cancer / edited by Ikram El Yazidi-Belkoura and Tony Lefebvre.
title_fullStr O-GlcNAcylation and Cancer / edited by Ikram El Yazidi-Belkoura and Tony Lefebvre.
title_full_unstemmed O-GlcNAcylation and Cancer / edited by Ikram El Yazidi-Belkoura and Tony Lefebvre.
title_auth O-GlcNAcylation and Cancer /
title_new O-GlcNAcylation and Cancer /
title_sort o-glcnacylation and cancer /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2022
physical 1 online resource (112 pages)
contents 1. Introduction -- 2. O-GlcNAcylation -- 2.2. Functions of O-GlcNAcylation -- 3. O-GlcNAcylation and Cancer -- 3.1. O-GlcNAcylation and Metastasis -- 3.2. O-GlcNAcylation and Receptor Tyrosine Kinase -- 3.3. O-GlcNAcylation and Resistance to Chemotherapy -- 3.4. O-GlcNAcylation as Prognostic Marker -- 4. O-GlcNAcylation and Immune Responses in Cancer -- 4.1. Overview of Immune System and O-GlcNAcylation -- 4.2. T Cell Activation and Differentiation Regulated by O-GlcNAcylation -- 4.3. Macrophage Differentiation and Activation by O-GlcNAcylation -- 4.4. O-GlcNAcylation and Tumor Microenvironment -- 5. Cancer Therapeutics Targeting O-GlcNAcylation -- 6. Conclusions and Future Perspectives -- Author Contributions -- Funding -- Conflicts of Interest -- Footnotes -- References.
isbn 3-0365-3082-7
callnumber-first Q - Science
callnumber-subject QP - Physiology
callnumber-label QP552
callnumber-sort QP 3552 G59 O453 42022
illustrated Not Illustrated
dewey-hundreds 500 - Science
dewey-tens 570 - Life sciences; biology
dewey-ones 572 - Biochemistry
dewey-full 572.68
dewey-sort 3572.68
dewey-raw 572.68
dewey-search 572.68
work_keys_str_mv AT yazidibelkouraikramel oglcnacylationandcancer
AT lefebvretony oglcnacylationandcancer
status_str n
ids_txt_mv (CKB)4920000001372612
(NjHacI)994920000001372612
(EXLCZ)994920000001372612
carrierType_str_mv cr
is_hierarchy_title O-GlcNAcylation and Cancer /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1764993889682325505
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02282nam a2200301 i 4500</leader><controlfield tag="001">993562132804498</controlfield><controlfield tag="005">20230329211429.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230329s2022 sz o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000001372612</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000001372612</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000001372612</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP552.G59</subfield><subfield code="b">.O453 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">572.68</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">O-GlcNAcylation and Cancer /</subfield><subfield code="c">edited by Ikram El Yazidi-Belkoura and Tony Lefebvre.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (112 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book gathers reviews and articles on the role of O-GlcNAcylation in cancer underlying the pharmacological targeting of the O-GlcNAcylation enzymes OGT and OGA as a promising anticancer strategy. Particular attention is paid to the involvement of O-GlcNAcylation in the regulation of transcription and as a link between nutrition and epigenetic dynamics or cellular energy metabolism. The role of O-GlcNAcylation in metastasis, immune responses, and resistance to chemotherapeutic agents is also discussed.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. Introduction -- 2. O-GlcNAcylation -- 2.2. Functions of O-GlcNAcylation -- 3. O-GlcNAcylation and Cancer -- 3.1. O-GlcNAcylation and Metastasis -- 3.2. O-GlcNAcylation and Receptor Tyrosine Kinase -- 3.3. O-GlcNAcylation and Resistance to Chemotherapy -- 3.4. O-GlcNAcylation as Prognostic Marker -- 4. O-GlcNAcylation and Immune Responses in Cancer -- 4.1. Overview of Immune System and O-GlcNAcylation -- 4.2. T Cell Activation and Differentiation Regulated by O-GlcNAcylation -- 4.3. Macrophage Differentiation and Activation by O-GlcNAcylation -- 4.4. O-GlcNAcylation and Tumor Microenvironment -- 5. Cancer Therapeutics Targeting O-GlcNAcylation -- 6. Conclusions and Future Perspectives -- Author Contributions -- Funding -- Conflicts of Interest -- Footnotes -- References.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Glycosylation.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3082-7</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yazidi-Belkoura, Ikram El,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lefebvre, Tony,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 12:13:43 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-09-22 08:09:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337923530004498&amp;Force_direct=true</subfield><subfield code="Z">5337923530004498</subfield><subfield code="8">5337923530004498</subfield></datafield></record></collection>